scholarly journals Influence of peri-procedural management of direct oral anticoagulants on the incidence of pocket hematoma in patients undergoing cardiac rhythm device implantation – The StimAOD study

2022 ◽  
Vol 14 (1) ◽  
pp. 79-80
Author(s):  
A.-C. Martin ◽  
O. Weizman ◽  
R. Garcia ◽  
N. Lellouche ◽  
A. Menet ◽  
...  
Keyword(s):  
Cardiac Rhythm ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Device Implantation ◽  
Pocket Hematoma

Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial

2014 ◽  
Vol 46 (3) ◽  
pp. 177-181 ◽  
Author(s):  
Wail Nammas ◽  
M. J. Pekka Raatikainen ◽  
Petri Korkeila ◽  
Juha Lund ◽  
Antti Ylitalo ◽  
...  
Keyword(s):  
Antithrombotic Therapy ◽  
Cardiac Rhythm ◽  
Device Implantation ◽  
Pocket Hematoma

scholarly journals Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement

2019 ◽  
Vol 2019 ◽  
pp. 1-3 ◽  
Author(s):  
Tania Ahuja ◽  
Scarlett Murphy ◽  
Daniel J. Sartori
Keyword(s):  
Antithrombotic Therapy ◽  
Left Atrial ◽  
Left Atrial Appendage ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Atrial Appendage ◽  
Left Atrial Appendage Occlusion ◽  
Device Implantation ◽  
Watchman Device ◽  
Device Placement

Antithrombotic therapy for stroke prevention in patients with atrial fibrillation (AF) has dramatically shifted from warfarin, a vitamin K antagonist, to the direct oral anticoagulants (DOACs) such as dabigatran, apixaban, and rivaroxaban. In patients with contraindications to oral anticoagulation, left atrial appendage occlusion (LAAO) devices, such as the Watchman™ device, may be considered; however, temporary postimplantation antithrombotic therapy is still a recommended practice. We present a case of complex antithrombotic management, post LAAO device implantation, designed to avoid drug interactions with concomitant rifampin use and remained necessary secondary to subsequent device leak. This case highlights the challenges of antithrombotic therapy post LAAO device placement in a complex, but representative, patient.

scholarly journals Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma

2019 ◽  
Vol 12 (10) ◽  
Author(s):  
Vidal Essebag ◽  
Jeff S. Healey ◽  
Jacqueline Joza ◽  
Pablo B. Nery ◽  
Eli Kalfon ◽  
...  
Keyword(s):  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Antiplatelet Agents ◽  
Pocket Hematoma
Sign in / Sign up

Export Citation Format

Share Document